Mydecine Reports its 2023 Annual General Shareholders' Meeting Results
May 10, 2023 16:05 ET
|
Mydecine Innovations Group Inc.
VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the...
U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation
June 17, 2022 07:00 ET
|
Mydecine Innovations Group Inc.
DENVER, June 17, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology aiming to transform the treatment of mental...
IBN (InvestorBrandNetwork) Announces Gamechangers LIVE Interview with Mydecine Innovations Group Inc. CEO Joshua Bartch
January 06, 2022 10:52 ET
|
InvestorBrandNetwork (IBN)
NEW YORK, Jan. 06, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – IBN (InvestorBrandNetwork), a multifaceted financial news and publishing company for private and public entities, today announces that...